{"disease":{"id":"urinary-bladder-diseases","name":"urinary bladder diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01972841","title":"This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3527,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":true},{"nct_id":"NCT01908829","title":"A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2174,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":true},{"nct_id":"NCT01638000","title":"A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1887,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":true},{"nct_id":"NCT02045862","title":"A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1829,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":true},{"nct_id":"NCT02386072","title":"A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)","phase":"","overall_status":"COMPLETED","enrollment_count":1524,"lead_sponsor_name":"Astellas Scientific & Medical Affairs, Inc.","has_results":false},{"nct_id":"NCT01340027","title":"A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1307,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":true},{"nct_id":"NCT02320773","title":"A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice","phase":"","overall_status":"COMPLETED","enrollment_count":863,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":false},{"nct_id":"NCT01613586","title":"A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":287,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":false},{"nct_id":"NCT05250908","title":"INTIBIA Pivotal Study","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":208,"lead_sponsor_name":"Coloplast A/S","has_results":false},{"nct_id":"NCT05153694","title":"Infectious Complications After Cystectomy: A Prospective Observational Study","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Ludwig-Maximilians - University of Munich","has_results":false},{"nct_id":"NCT06237920","title":"Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"The Netherlands Cancer Institute","has_results":false},{"nct_id":"NCT03245242","title":"Pediatric Urology Recovery After Surgery Endeavor (PURSUE)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":85,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05878951","title":"Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT04442724","title":"Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT03845725","title":"Falls and Balance of Patients With Parkinson's Disease With Urinary Disturbance","phase":"","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Ordu University","has_results":false},{"nct_id":"NCT04161716","title":"Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans (DETTECH)","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"BioSerenity","has_results":false},{"nct_id":"NCT01060254","title":"A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","has_results":false},{"nct_id":"NCT03123055","title":"A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":28,"lead_sponsor_name":"Rainier Therapeutics","has_results":true},{"nct_id":"NCT04914442","title":"Eosinophilic Cystitis Mimicking Urothelial Neoplasia","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Al-Azhar University","has_results":false},{"nct_id":"NCT03081858","title":"Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Lipac Oncology LLC","has_results":true},{"nct_id":"NCT05643963","title":"The COOKER-BLADDER Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Roland Seiler-Blarer","has_results":false},{"nct_id":"NCT03843073","title":"Connected Catheter- Safety and Effectiveness Study","phase":"NA","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Spinal Singularity","has_results":false}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}